Related Experiment Video
Updated: Feb 24, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
A Complex Case of Ornithine Transcarbamylase Deficiency in a Patient With Severe Comorbid Conditions
Mobeen Khan1, Sardar Ahmad Rafique2, Suleman Khan2
1Trainee Medical Officer, MTI Khyber Teaching Hospital Peshawar Pakistan.
Abstract:
Ornithine transcarbamylase deficiency (OTCD) is the most common urea-cycle disorder, but it is often overlooked in Pakistan. It can present after the neonatal period with symptoms resembling sepsis and significant respiratory alkalosis. We report a 4-month-old boy with fever, lethargy, poor feeding, and loose stools for 5 days. He arrived with a rapid heart rate and quick breathing. His arterial blood gas showed a pH of 7.65, pCO2 of 14 mmHg, and HCO3 - of 15.5 mmol/L. Plasma ammonia levels were elevated at 78.1 μmol/L (reference range 11-32). A quantitative amino acid test revealed greatly increased glutamate (263 μmol/L; reference range 18-98) with low citrulline (6 μmol/L; reference range 16-32) and a normal ornithine/arginine ratio, which matches the pattern seen in partial OTCD. A contrast-enhanced CT scan of the brain showed widespread leptomeningeal enhancement and mild enlargement of the bifronto-temporal subarachnoid spaces. An echocardiogram found a small secundum atrial septal defect (ASD) and a tiny patent ductus arteriosus (PDA), with normal function in both ventricles. The patient was treated for suspected sepsis and high ammonia levels using sodium benzoate, L-arginine, L-carnitine, micronutrient support, and a low-protein diet based on formula (Basic-P/Morinaga BF-1). This led to steady improvements in his clinical condition and blood work. This case highlights three key points for resource-limited settings: (i) check ammonia levels early in any infant with unexplained encephalopathy and respiratory alkalosis; (ii) a low-citrulline/normal-ornithine profile should prompt evaluation for OTCD, even with mild hyperammonemia; and (iii) starting nitrogen-scavenging therapy and adjusting dietary protein can prevent the need for dialysis. Documenting these presentations helps raise awareness in the region and emphasizes the importance of access to confirmatory molecular testing and family counseling when newborn screening is not available.
Related Concept Videos
Inborn Errors of Metabolism
Urea Cycle
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Chronic Kidney Disease II: Clinical Manifestations
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase